Recent 8-K filings for GRAL

• June 1, 2026, 4:07 PM ET leadership materiality 0.70 neutral item 5.02item 8.01item 9.01

  GRAIL appoints Joshua Ofman as CEO with amended compensation and severance

  Joshua Ofman appointed CEO effective June 1, 2026; annual base salary $800,000.

• May 5, 2026, 7:59 PM ET earnings materiality 0.65 neutral item 2.02item 9.01

  GRAIL Q1 2026: revenue $40.8M (up 28%), Galleri volume 56k+ (up 50%), net loss $93.2M

  Total revenue $40.8M (+28% YoY); Galleri revenue $39.8M (+37%); test volume >56,000 (+50%).

• February 19, 2026, 6:59 PM ET other material materiality 0.80 neutral item 2.02item 8.01item 9.01

  NHS-Galleri trial misses primary endpoint but shows Stage IV reduction; Q4 rev $43.6M

  Primary endpoint of significant Stage III-IV reduction not met; substantial Stage IV reduction observed across 12 deadly cancers.

• January 12, 2026, 6:59 PM ET other material materiality 0.40 neutral item 2.02item 9.01

  GRAIL to present preliminary Q4/FY2025 results at JP Morgan Healthcare Conference

  Presentation at 2026 J.P. Morgan Healthcare Conference on January 12, 2026.

• November 14, 2025, 6:59 PM ET other material materiality 0.60 neutral item 8.01item 9.01

  GRAIL enters $300M ATM equity distribution agreement with Morgan Stanley and TD Securities

  Company may sell up to $300M of common stock (max 6.9M shares) at-the-market.

• November 12, 2025, 6:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  GRAIL Q3 revenue $36.2M (+26% YoY); U.S. Galleri revenue $32.6M (+28%)

  Net loss $89.0M, improving 29% YoY; adjusted EBITDA $(71.7)M.

• October 20, 2025, 7:59 PM ET other material materiality 0.70 neutral item 1.01item 3.02item 9.01

  GRAIL raises $325M in private placement at $70.05/share; funds operations into 2030

  Gross proceeds ~$325M from 4,639,543 shares/pre-funded warrants at $70.05/share.

• October 16, 2025, 7:59 PM ET M&A materiality 0.85 positive item 1.01item 2.02item 3.02item 7.01item 9.01

  Samsung invests $110M in GRAIL at $70.05/sh; exclusive Galleri rights in South Korea; Q3 prelim results

  Samsung C&T and Samsung Electronics invest $110M in GRAIL at $70.05/share (~1.57M shares) via private placement.

• September 18, 2025, 7:59 PM ET other material materiality 0.75 neutral item 1.01item 2.03item 9.01

  GRAIL signs 11-year lease for 75,556 RSF Sunnyvale HQ; base rent ~$449,558/month

  11-year lease for ~75,556 RSF office/lab at 250 S. Matilda Ave, Sunnyvale, CA.

• August 12, 2025, 7:59 PM ET earnings materiality 0.60 neutral item 2.02item 9.01

  GRAIL Q2 revenue $35.5M (+11% YoY); net loss $114M includes $28M impairment

  U.S. Galleri revenue $34.2M (+21% YoY); Galleri tests sold >45,000 (+29% YoY).

• May 30, 2025, 7:59 PM ET other material materiality 0.15 neutral item 5.07

  GRAIL stockholders elect William Chase as Class I director; ratify EY as auditor

  William Chase elected with 19.0M votes for, 1.2M withheld, and 9.4M broker non-votes.

• May 16, 2025, 7:59 PM ET other material materiality 0.30 neutral item 5.02item 9.01

  GRAIL amends offer letters for President and CFO, enhancing severance benefits

  Josh Ofman annual base salary remains $655,000; Aaron Freidin base salary $560,000; target bonus unchanged at 50% of base.

• May 13, 2025, 7:59 PM ET earnings materiality 0.65 positive item 2.02item 9.01

  GRAIL Q1 revenue $31.8M (+19% YoY); Galleri U.S. revenue $28.7M (+22%); net loss improves

  Total revenue $31.8M, up 19% YoY; U.S. Galleri revenue $28.7M, up 22% YoY.

• February 20, 2025, 6:59 PM ET earnings materiality 0.55 neutral item 2.02item 9.01

  GRAIL Q4 rev $38.3M (+26%), net loss $97.1M; FY Galleri rev $108.6M (+45%); adds TRICARE coverage

  Q4 total revenue $38.3M (+26% YoY); Q4 Galleri revenue $31.6M (+39% YoY).

• January 15, 2025, 6:59 PM ET earnings materiality 0.50 neutral item 2.02item 9.01

  GRAIL presents preliminary Q4/FY2024 financial update at JPMorgan conference; specific figures not in excerpt

  Corporate update and preliminary Q4 and FY2024 financial results presented at J.P. Morgan Healthcare Conference on Jan 15, 2025.

• November 12, 2024, 6:59 PM ET earnings materiality 0.70 negative item 2.02item 9.01

  GRAIL Q3 2024: Galleri revenue $25.4M (+52% YoY); net loss $(125.7)M

  Total revenue $28.7M (+38% YoY); Galleri revenue $25.4M (+52% YoY).

• October 22, 2024, 7:59 PM ET leadership materiality 0.30 neutral item 5.02item 7.01item 9.01

  GRAIL appoints Sarah Krevans to Board of Directors, effective Oct 21

  Krevans appointed as Class II director; will serve on Audit, Compensation, and Nominating & Governance Committees.

• August 13, 2024, 7:59 PM ET earnings materiality 0.75 neutral item 2.02item 9.01

  GRAIL Q2 revenue up 43% to $32M; net loss $(1.59)B due to $1.42B impairment

  Revenue of $32.0M (+43% YoY), driven by Galleri test sales exceeding 215,000 cumulative units.

• August 6, 2024, 7:59 PM ET other material materiality 0.30 neutral item 7.01

  GRAIL Q2 results included in Illumina earnings; standalone report due Aug 13

  Illumina announced Q2 2024 results including GRAIL's operations through June 24, 2024 separation date.

• July 2, 2024, 7:59 PM ET other material materiality 0.50 neutral item 5.02item 9.01

  GRAIL converts pre-spin awards to 6.6M RSUs; sets 2024 Plan share limit at 8.66M

  Cash-based equity awards converted to 6,589,187 RSUs under 2024 Plan based on VWAP over four days post-Distribution.

• June 27, 2024, 7:59 PM ET other material materiality 0.90 negative item 2.06

  GRAIL expects $888.9M goodwill impairment & ~$420M IPR&D charge in Q2 2024

  Goodwill impairment charge of $888.9 million, full remaining carrying value as of March 31, 2024.

• June 24, 2024, 7:59 PM ET M&A materiality 0.95 positive item 1.01item 3.03item 5.03item 5.01item 5.02item 9.01

  GRAIL completes spin-off from Illumina; receives $932M funding, starts trading June 25

  Illumina distributed 85.5% of GRAIL shares to its shareholders (1 per 6 shares) on June 24, 2024; Illumina retains 14.5%.

• June 12, 2024, 7:59 PM ET leadership materiality 0.50 neutral item 5.02

  GRAIL LLC names three directors, including Illumina CFO and General Counsel

  Effective June 11, 2024, Illumina (sole member) established GRAIL's board of directors.

• June 6, 2024, 7:59 PM ET other material materiality 0.55 neutral item 8.01

  GRAIL distribution date June 24; when-issued trading June 12-24, regular-way June 25

  Distribution effective 12:01 AM ET on June 24, 2024, as a pro rata dividend of at least 85.5% of GRAIL shares from Illumina.

• June 3, 2024, 7:59 PM ET other material materiality 0.60 neutral item 8.01item 9.01

  GRAIL spin-off from Illumina declared effective; distribution details set

  SEC declared effective Form 10 for GRAIL spin-off on June 3, 2024.

Executive changes

Earnings & guidance

Materiality & sentiment trend

Max materiality 0.95 · Median 0.60 · Most common event other_material

4 positive 2 negative 19 neutral

source · GRAL on sec.gov